These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32718075)

  • 41. Evaluation of tumour heterogeneity by
    Liu C; Hu S; Xu X; Zhang Y; Wang B; Song S; Yang Z
    Breast Cancer Res; 2022 Aug; 24(1):57. PubMed ID: 36028895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Validity of 16α-[
    van Geel JJL; Boers J; Elias SG; Glaudemans AWJM; de Vries EFJ; Hospers GAP; van Kruchten M; Kuip EJM; Jager A; Menke-van der Houven van Oordt WC; van der Vegt B; de Vries EGE; Schröder CP;
    J Clin Oncol; 2022 Nov; 40(31):3642-3652. PubMed ID: 35584346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New PET tracers for evaluation of solid tumor response to therapy.
    Larson SM; Schoder H
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):158-66. PubMed ID: 19293764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fully-automated synthesis of 16β-(18)F-fluoro-5α-dihydrotestosterone (FDHT) on the ELIXYS radiosynthesizer.
    Lazari M; Lyashchenko SK; Burnazi EM; Lewis JS; van Dam RM; Murphy JM
    Appl Radiat Isot; 2015 Sep; 103():9-14. PubMed ID: 26046518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Predictive Value of Early Changes in
    He M; Liu C; Shi Q; Sun Y; Zhang Y; Xu X; Yuan H; Zhang Y; Liu Y; Liu G; Di G; Yang Z; Wang Z; Shao Z
    Oncologist; 2020 Nov; 25(11):927-936. PubMed ID: 32272493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of estrogen expression of breast cancer using
    Seenu V; Sharma A; Kumar R; Suhani S; Prashanth A; Mathur S; Parshad R
    World J Nucl Med; 2020; 19(3):233-239. PubMed ID: 33354178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Application of 18 F-FES PET in Clinical Cancer Care : A Systematic Review.
    Huang YT; Chen TW; Chen LY; Huang YY; Lu YS
    Clin Nucl Med; 2023 Sep; 48(9):785-795. PubMed ID: 37482660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.
    Vargas HA; Wassberg C; Fox JJ; Wibmer A; Goldman DA; Kuk D; Gonen M; Larson SM; Morris MJ; Scher HI; Hricak H
    Radiology; 2014 Apr; 271(1):220-9. PubMed ID: 24475817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PET imaging of steroid receptor expression in breast and prostate cancer.
    Hospers GA; Helmond FA; de Vries EG; Dierckx RA; de Vries EF
    Curr Pharm Des; 2008; 14(28):3020-32. PubMed ID: 18991716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 18F-FES PET/CT Improves the Detection of Intraorbital Metastases in Estrogen-Receptor-Positive Breast Cancer: Two Representative Cases and Review of the Literature.
    Bodapati S; Abraham P; Chen A; Guilbault D; McDonald M; Matro J; Shatsky R; Obrzut S
    Tomography; 2022 Apr; 8(2):1060-1065. PubMed ID: 35448720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.
    He S; Wang M; Yang Z; Zhang J; Zhang Y; Luo J; Zhang Y
    PLoS One; 2016; 11(7):e0159916. PubMed ID: 27467716
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z
    Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
    Paquette M; Ouellet R; Archambault M; Croteau É; Lecomte R; Bénard F
    Nucl Med Biol; 2012 Jan; 39(1):57-64. PubMed ID: 22079037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Randomized Feasibility Study of
    Chae SY; Kim SB; Ahn SH; Kim HO; Yoon DH; Ahn JH; Jung KH; Han S; Oh SJ; Lee SJ; Kim HJ; Son BH; Gong G; Lee HS; Moon DH
    J Nucl Med; 2017 Apr; 58(4):563-568. PubMed ID: 27688475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy.
    Dehdashti F; Wu N; Ma CX; Naughton MJ; Katzenellenbogen JA; Siegel BA
    Nat Commun; 2021 Feb; 12(1):733. PubMed ID: 33531464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel methods and tracers for breast cancer imaging.
    Linden HM; Dehdashti F
    Semin Nucl Med; 2013 Jul; 43(4):324-9. PubMed ID: 23725994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 18F-Fluoroestradiol Positron Emission Tomography in Breast Cancer Patients: Systematic Review of the Literature & Meta-Analysis.
    Evangelista L; Guarneri V; Conte PF
    Curr Radiopharm; 2016; 9(3):244-257. PubMed ID: 27774910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.
    Fox JJ; Gavane SC; Blanc-Autran E; Nehmeh S; Gönen M; Beattie B; Vargas HA; Schöder H; Humm JL; Fine SW; Lewis JS; Solomon SB; Osborne JR; Veach D; Sawyers CL; Weber WA; Scher HI; Morris MJ; Larson SM
    JAMA Oncol; 2018 Feb; 4(2):217-224. PubMed ID: 29121144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET imaging of oestrogen receptors in patients with breast cancer.
    van Kruchten M; de Vries EGE; Brown M; de Vries EFJ; Glaudemans AWJM; Dierckx RAJO; Schröder CP; Hospers GAP
    Lancet Oncol; 2013 Oct; 14(11):e465-e475. PubMed ID: 24079874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can
    Gupta M; Datta A; Choudhury PS; Dsouza M; Batra U; Mishra A
    World J Nucl Med; 2017; 16(2):133-139. PubMed ID: 28553180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.